Literature DB >> 10648932

Ribosome display: an in vitro method for selection and evolution of antibodies from libraries.

C Schaffitzel1, J Hanes, L Jermutus, A Plückthun.   

Abstract

Combinatorial approaches in biology require appropriate screening methods for very large libraries. The library size, however, is almost always limited by the initial transformation steps following its assembly and ligation, as other all screening methods use cells or phages and viruses derived from them. Ribosome display is the first method for screening and selection of functional proteins performed completely in vitro and thus circumventing many drawbacks of in vivo systems. We review here the principle and applications of ribosome display for generating high-affinity antibodies from complex libraries. In ribosome display, the physical link between genotype and phenotype is accomplished by a mRNA-ribosome-protein complex that is used for selection. As this complex is stable for several days under appropriate conditions, very stringent selections can be performed. Ribosome display allows protein evolution through a built-in diversification of the initial library during selection cycles. Thus, the initial library size no longer limits the sequence space sampled. By this method, scFv fragments of antibodies with affinities in the low picomolar range have been obtained. As all steps of ribosome display are carried out entirely in vitro, reaction conditions of individual steps can be tailored to the requirements of the protein species investigated and the objectives of the selection or evolution experiment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10648932     DOI: 10.1016/s0022-1759(99)00149-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  35 in total

1.  Construction and characterization of protein libraries composed of secondary structure modules.

Authors:  Tomoaki Matsuura; Andreas Ernst; Andreas Plückthun
Journal:  Protein Sci       Date:  2002-11       Impact factor: 6.725

Review 2.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

3.  Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activity.

Authors:  Nitya S Ramadoss; John N Alumasa; Lin Cheng; Yu Wang; Sharon Li; Benjamin S Chambers; Hoon Chang; Arnab K Chatterjee; Achim Brinker; Ingo H Engels; Kenneth C Keiler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

Review 4.  Engineering the variable region of therapeutic IgG antibodies.

Authors:  Tomoyuki Igawa; Hiroyuki Tsunoda; Taichi Kuramochi; Zenjiro Sampei; Shinya Ishii; Kunihiro Hattori
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

5.  Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B.

Authors:  Fatemeh Salimi; Mehdi Forouzandeh Moghadam; Masoumeh Rajabibazl
Journal:  Mol Biol Rep       Date:  2018-09-17       Impact factor: 2.316

Review 6.  Combinatorial antibody libraries: new advances, new immunological insights.

Authors:  Richard A Lerner
Journal:  Nat Rev Immunol       Date:  2016-07-04       Impact factor: 53.106

Review 7.  Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering.

Authors:  Cristina Parola; Daniel Neumeier; Sai T Reddy
Journal:  Immunology       Date:  2017-10-30       Impact factor: 7.397

8.  Large-Scale, Quantitative Protein Assays on a High-Throughput DNA Sequencing Chip.

Authors:  Curtis J Layton; Peter L McMahon; William J Greenleaf
Journal:  Mol Cell       Date:  2019-03-07       Impact factor: 17.970

9.  In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.

Authors:  Xikun Zhou; Ji Qiu; Zhen Wang; Nongyu Huang; Xiaolei Li; Qian Li; Yinbing Zhang; Chengjian Zhao; Can Luo; Nannan Zhang; Xiu Teng; Zhongwen Chen; Xiao Liu; Xianlian Yu; Wenling Wu; Yu-quan Wei; Jiong Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-07       Impact factor: 4.553

10.  A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.

Authors:  Davide Ferrari; Valentina Garrapa; Massimo Locatelli; Angelo Bolchi
Journal:  Mol Biotechnol       Date:  2020-01       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.